178 results on '"Nagashio, Ryo"'
Search Results
2. Prognostic significance of G6PD expression and localization in lung adenocarcinoma
3. Vulnerability to stress in mouse offspring is ameliorated when pregnant dams are provided a chewing stick during prenatal stress
4. Insight into the significance of CD8+ tumor‐infiltrating lymphocytes in squamous cell lung cancer
5. Prognostic significance of S100A16 subcellular localization in lung adenocarcinoma
6. Late Somatic Gene 2 disrupts parental spheroids cooperatively with Volvox hatching enzyme A in Volvox
7. A new marker, insulinoma-associated protein 1 (INSM1), for high-grade neuroendocrine carcinoma of the uterine cervix: Analysis of 37 cases
8. Insight into the significance of CD8+ tumor‐infiltrating lymphocytes in squamous cell lung cancer.
9. The clinicopathological significance of Lgr5 expression in lung adenocarcinoma
10. Clinicopathological Significance of S100A14 Expression in Lung Adenocarcinoma
11. DJ-1 Expression Might Serve as a Biologic Marker in Patients with Bladder Cancer
12. Diagnostic significance of NAP1L1 expression in patients with lung adenocarcinoma
13. Expression of RACK1 is a novel biomarker in pulmonary adenocarcinomas
14. Prevalent and up-regulated vimentin expression in micropapillary components of lung adenocarcinomas and its adverse prognostic significance
15. Detection of tumor-specific autoantibodies in sera of patients with lung cancer
16. Prognostic significance of galectin‐3 expression in patients with resected NSCLC treated with platinum‐based adjuvant chemotherapy
17. A case of pulmonary papillary adenoma: Possible relationship between tumor histogenesis/tumorigenesis and fibroblast growth factor receptor 2 IIIb
18. Carcinogenetic risk estimation based on quantification of DNA methylation levels in liver tissue at the precancerous stage
19. Copy number alterations in urothelial carcinomas: their clinicopathological significance and correlation with DNA methylation alterations
20. Prognostic significance of NAP1L1 expression in patients with early lung adenocarcinoma
21. Expression of CA2 and CA9 carbonic anhydrases in ulcerative colitis and ulcerative colitis‐associated colorectal cancer
22. TRAP1 is a predictive biomarker of platinum-based adjuvant chemotherapy benefits in patients with resected lung adenocarcinoma
23. Significant high expression of cytokeratins 7, 8, 18, 19 in pulmonary large cell neuroendocrine carcinomas, compared to small cell lung carcinomas
24. Proteomics of tumor-specific proteins in cerebrospinal fluid of patients with astrocytoma: Usefulness of gelsolin protein
25. Expression of autocrine motility factor mRNA is a poor prognostic factor in high-grade astrocytoma
26. Cytoskeleton-Associated Protein 4 Is a Novel Serodiagnostic Marker for Lung Cancer
27. Prognostic significance of IMMT expression in surgically‐resected lung adenocarcinoma
28. TROY expression is associated with pathological stage and poor prognosis in patients treated with radical cystectomy
29. Clinicopathological and prognostic significance of nuclear UGDH localization in lung adenocarcinoma
30. Acquisition of tumor marker candidate proteins using two-dimensional gel electrophoresis
31. Basigin expression as a prognostic indicator in stage I pulmonary adenocarcinoma
32. S100A16, a promising candidate as a prognostic marker for platinum-based adjuvant chemotherapy in resected lung adenocarcinoma
33. Calnexin is a novel sero-diagnostic marker for lung cancer
34. S100A16, a promising candidate as a prognostic marker for platinum-based adjuvant chemotherapy in resected lung adenocarcinoma
35. Prognostic significance of nestin expression in patients with resected non-small cell lung cancer treated with platinum-based adjuvant chemotherapy; relationship between nestin expression and epithelial to mesenchymal transition related markers
36. Detection method for membranous proteins and their utility as a sero-diagnostic markers for lung cancer
37. Proteome analysis using the cancer stem cell-like micropapillary adenocarcinoma cell line
38. Impact of PD-L1 Expression in Patients with Surgically Resected Non-Small-Cell Lung Cancer
39. Application of markers obtained by various proteomic methods to resected non-small cell lung cancer treated with platinum-based adjuvant chemotherapy
40. Search of sero-diagnostic marker using the Reverse-phase protein array
41. Late Somatic Gene 2 disrupts parental spheroids cooperatively with Volvox hatching enzyme A in Volvox
42. Prognostic significance of nestin expression in patients with resected non-small cell lung cancer treated with platinum-based adjuvant chemotherapy
43. Co-expression of S100A14 and S100A16 is a predictive marker for platinum-based adjuvant chemotherapy in resected lung adenocarcinomas
44. Clinicopathological Significance of S100A10 Expression in Lung Adenocarcinomas
45. Serum Anti-Gal-3 Autoantibody is a Predictive Marker of the Efficacy of Platinum-Based Chemotherapy against Pulmonary Adenocarcinoma
46. S100A16 is a Prognostic Marker for Lung Adenocarcinomas
47. Prognostic Significance of MYH9 Expression in Resected Non-Small Cell Lung Cancer
48. High Expression Level of Preoperative Serum Uroplakin III is Associated with Biologically Aggressive Bladder Cancer
49. Diagnostic and Prognostic Significances of MUC5B and TTF-1 Expressions in Resected Non-Small Cell Lung Cancer
50. Acquisition of tumor-associated antigens using autoantibodies in sera from patients with cancer
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.